Abstract：Objective: To Compare the difference between the support effects of high-flow nasal cannula(HFNC) and CPAP in post-operative congenital heart disease(CHD) children with severe type I respiratory failure. Methods: From January 2018 to December 2018, 44 children were treated with HFNC (22 cases) and CPAP(22 cases) for severe type I respiratory failure after operation of congenital heart disease. PaO2,SpO2,PaCO2,RR,RW score,duration of invasive ventilation, reintubation rate,duration of ICU,hospital stay,comfort score, nasal crush,abdominal distention,regurgitation and aspiration ,gas leakage are compared between the two groups. Results: Comfort score, PaCO2,RR,RW score,nasal crush,abdominal distention,regurgitation and aspiration was lower in the HFNC group. There were no statistical significance in PaO2,SpO2,duration of invasive ventilation, reintubation rate,duration of ICU,hospital stay and gas leakage between the two groups. Conclusion: Comparing the support to post-operative children with CHD and severe type I respiratory failure,HFNC is better than CPAP.
宋航, 李青, 郭士勇, 武怡. 高流量吸氧与CPAP在儿童先心病术后严重I型呼吸衰竭中支持作用的比较[J]. 河北医学, 2019, 25(7): 1158-1161.
SONG Hang , LI Qing, GUO Shiyong, Wu Yi. Comparison between High-flow Nasal Cannula and CPAP in Post-operative Congenital Heart Disease Children with Severe Type I Respiratory Failure. HeBei Med, 2019, 25(7): 1158-1161.
[1] Miller MP.Pressure characteristics of mechanical ventilation and incidence of pneumothorax before and after the implementation of protective lung strategies in the management of pediatric patients with severe ARDS[J].Chest,2018,134(5):164~167. [2] Sema Yilmaz.Noninvasive ventilation in cancer children with acute respiratory failure[J]急性病杂志(英文版),2017,6(1):158~160. [3] M.Espinosa.Evaluation of the influence of cardiac resynchronization therapy on sleep apnea syndrome[J].Archives of Cardiovascular Diseases Supplements,2018,10(204):56~58. [4] Jean-Pierre Frat.Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial[J].The Lancet Respiratory Medicine,2016,26(16):646~652.
2019, Vol. 25 
冀公网安备13080202000677号